An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

National Agricultural Library
U.S. Department of Agriculture
  1. Home
  2. Human Nutrition and Food Safety
  3. Research Publications (Food Safety)

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 1 - 25 of 36

  1. Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study

    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19

  2. Evaluation of early antibiotic use in patients with non‐severe COVID‐19 without bacterial infection

    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19

  3. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice

    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19

  4. High dose ivermectin for the early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof of concept clinical trial

    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19

  5. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): Emre Kara, Kutay Demirkan, Serhat Unal

      • COVID-19

  6. Lactoferrin as potential preventative and adjunct treatment for COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): Raymond Chang, Tzi Bun Ng, Wei-Zen Sun

      • COVID-19

  7. Combating devastating COVID-19 by drug repurposing

    • International Journal of Antimicrobial Agents

    • Author(s): Ashish Yashwantrao Pawar

      • COVID-19

  8. COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)

    • International Journal of Antimicrobial Agents

    • Author(s): Yang Song, Min Zhang, Ling Yin, Kunkun Wang, Yiyi Zhou, Mi Zhou, Yun Lu

      • COVID-19

  9. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology

    • International Journal of Antimicrobial Agents

    • Author(s): Arianna Pani, Marinella Lauriola, Alessandra Romandini, Francesco Scaglione

      • COVID-19

  10. Corticosteroid therapy for patients with COVID-19 pneumonia: a before–after study

    • International Journal of Antimicrobial Agents

    • Author(s): Firouzé Bani-Sadr, Maxime Hentzien, Madeline Pascard, Yohan N'Guyen, Amélie Servettaz, Laurent Andreoletti, Lukshe Kanagaratnam, Damien Jolly

      • COVID-19

  11. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic

    • International Journal of Antimicrobial Agents

    • Author(s): Satyajit Tripathy, Barsha Dassarma, Somenath Roy, Hlupheka Chabalala, Motlalepula Gilbert Matsabisa

      • COVID-19

  12. Extra-respiratory manifestations of COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): Chih-Cheng Lai, Wen-Chien Ko, Ping-Ing Lee, Shio-Shin Jean, Po-Ren Hsueh

      • COVID-19

  13. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal

    • International Journal of Antimicrobial Agents

    • Author(s): Jacques Fantini, Henri Chahinian, Nouara Yahi

      • COVID-19

  14. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking

    • International Journal of Antimicrobial Agents

    • Author(s): Ran Yu, Liang Chen, Rong Lan, Rong Shen, Peng Li

      • COVID-19

  15. Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): Hua Shi, Chaomin Zhou, Pinghong He, Sheng Huang, Youjun Duan, Xuesheng Wang, Kexiong Lin, Chao Zhou, Xiangyan Zhang, Yan Zha

      • COVID-19

  16. Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors

    • International Journal of Antimicrobial Agents

    • Author(s): Jun He, Lijun Hu, Xiaojun Huang, Chenran Wang, Zhimin Zhang, Ying Wang, Dongmei Zhang, Wencai Ye

      • COVID-19

  17. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

    • International Journal of Antimicrobial Agents

    • Author(s): Atul Sharma, Swapnil Tiwari, Manas Kanti Deb, Jean Louis Marty

      • COVID-19

  18. Widely available lysosome targeting agents should be considered as potential therapy for COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): J. Homolak, I. Kodvanj

      • COVID-19

  19. Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein

    • International Journal of Antimicrobial Agents

    • Author(s): Naveen Vankadari

      • COVID-19

  20. Procalcitonin levels in COVID-19 patients

    • International Journal of Antimicrobial Agents

    • Author(s): Rui Hu, Chaofei Han, Shiyao Pei, Mingzhu Yin, Xiang Chen

      • COVID-19

  21. Is teicoplanin a complementary treatment option for COVID-19? The question remains

    • International Journal of Antimicrobial Agents

    • Author(s): Giancarlo Ceccarelli, Francesco Alessandri, Gabriella d'Ettorre, Cristian Borrazzo, Ornella Spagnolello, Alessandra Oliva, Franco Ruberto, Claudio M. Mastroianni, Francesco Pugliese, Mario Venditti, Intensive Care COVID-19 Study Group of Sapienza University

      • COVID-19

  22. Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports

    • International Journal of Antimicrobial Agents

    • Author(s): Valeria Gaspari, Corrado Zengarini, Sonia Greco, Valeria Vangeli, Antonio Mastroianni

      • COVID-19

  23. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

    • International Journal of Antimicrobial Agents

    • Author(s): Arturo Ciccullo, Alberto Borghetti, Lorenzo Zileri Dal Verme, Alberto Tosoni, Francesca Lombardi, Matteo Garcovich, Federico Biscetti, Massimo Montalto, Roberto Cauda, Simona Di Giambenedetto, GEMELLI AGAINST COVID Group

      • COVID-19

  24. Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b

    • International Journal of Antimicrobial Agents

    • Author(s): Sun In Hong, Byung-Han Ryu, Yong Pil Chong, Seungjun Lee, Sunjoo Kim, Ho Cheol Kim, Kyung-Wook Hong, In-Gyu Bae, Oh-Hyun Cho

      • COVID-19

  25. Tocilizumab administration in a refractory case of COVID-19

    • International Journal of Antimicrobial Agents

    • Author(s): Farzaneh Dastan, Seyed Alireza Nadji, Ali Saffaei, Payam Tabarsi

      • COVID-19